Category
CLSI C43-A2 – Gas Chromatography/Mass Spectrometry Confirmation of Drugs; Approved Guideline-Second Edition, C43A2E
This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI’s library.
This document provides guidance on establishing uniform practices necessary to produce quality data for quantitation and identification of a drug or drug metabolite using the gas chromatography/mass spectrometry method. Specific quality assurance criteria for maintaining and documenting optimal instrument performance are also presented.
Product Details
- Published:
- 03/01/2010
- ISBN(s):
- 1562387200
- File Size:
- 1 file , 2 MB
- Note:
- This product is unavailable in Russia, Belarus
Related products
-
CLSI QMS21 (R2021)
$180.00$108.00Add to cartPurchasing and Inventory Management, 1st Edition, QMS21Ed1E
Published by Publication Date Number of Pages CLSI 11/01/2016 114 -
CLSI QMS18
$180.00$108.00Add to cartProcess Management, First Edition; QMS18Ed1E
Published by Publication Date Number of Pages CLSI 03/10/2015 132 -
CLSI X06R
$180.00$108.00Add to cartProceedings From the QC for the Future Workshop; A Report, X06-R
Published by Publication Date Number of Pages CLSI 06/01/2005 11 -
CLSI QMS26
$180.00$108.00Add to cartManaging Laboratory Records, 1st Edition, QMS26Ed1E
Published by Publication Date Number of Pages CLSI 04/14/2021 80